CSIMarket
Adaptimmune Therapeutics Plc  (ADAP)
Other Ticker:  
 
 

Adaptimmune Therapeutics Plc's Yearly Net Cash Flow Growth 5 Years

 

Select the Comparisons : Select the Ratio:



ADAP Annual Net Cash Flow Growth

2023
2022
2021
2020
2019
Y / Y Annual Net Cash Flow Change - - 1271.38 % - -
Annual Net Cash Flow (in millions $) $37.42 $-42.06 $90.18 $6.58 $-17.57


Annual Net Cash Flow Growth Comment
In the fiscal year ended 2023, company achieved Annual Net Cash Flow of $37.42 millions compare to net cash outflow of $-42.06 millions realized a year before.

Adaptimmune Therapeutics Plc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Net Cash Flow within Healthcare SectorY/Y Net Cash Flow Growth %2023 Annual Net Cash Flow
Vertex Pharmaceuticals Inc